Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guiding the starting dose of the once-daily formulation of tacrolimus in "de novo" adult renal transplant patients: a population approach.
Fernández-Alarcón B, Nolberger O, Vidal-Alabró A, Rigo-Bonnin R, Grinyó JM, Melilli E, Montero N, Manonelles A, Coloma A, Favà A, Codina S, Cruzado JM, Colom H, Lloberas N. Fernández-Alarcón B, et al. Among authors: coloma a. Front Pharmacol. 2024 Sep 19;15:1456565. doi: 10.3389/fphar.2024.1456565. eCollection 2024. Front Pharmacol. 2024. PMID: 39364055 Free PMC article.
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction.
Lloberas N, Grinyó JM, Colom H, Vidal-Alabró A, Fontova P, Rigo-Bonnin R, Padró A, Bestard O, Melilli E, Montero N, Coloma A, Manonelles A, Meneghini M, Favà A, Torras J, Cruzado JM. Lloberas N, et al. Among authors: coloma a. Kidney Int. 2023 Oct;104(4):840-850. doi: 10.1016/j.kint.2023.06.021. Epub 2023 Jun 28. Kidney Int. 2023. PMID: 37391040 Free article. Clinical Trial.
Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio.
Vidal-Alabró A, Colom H, Fontova P, Cerezo G, Melilli E, Montero N, Coloma A, Manonelles A, Favà A, Cruzado JM, Torras J, Grinyó JM, Lloberas N. Vidal-Alabró A, et al. Among authors: coloma a. Nefrologia (Engl Ed). 2024 Mar-Apr;44(2):204-216. doi: 10.1016/j.nefroe.2024.03.019. Epub 2024 Apr 12. Nefrologia (Engl Ed). 2024. PMID: 38614890 Free article.
Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis.
Oliveras L, Coloma A, Lloberas N, Lino L, Favà A, Manonelles A, Codina S, Couceiro C, Melilli E, Sharif A, Hecking M, Guthoff M, Cruzado JM, Pascual J, Montero N. Oliveras L, et al. Among authors: coloma a. Transplant Rev (Orlando). 2024 Jul;38(3):100856. doi: 10.1016/j.trre.2024.100856. Epub 2024 May 1. Transplant Rev (Orlando). 2024. PMID: 38723582 Review.
Randomized clinical trial of non-antibiotic prophylaxis with d-Mannose plus Proanthocyanidins vs. Proanthocyanidins alone for urinary tract infections and asymptomatic bacteriuria in de novo kidney transplant recipients: The Manotras study.
Rau M, Santelli A, Martí S, Díaz MI, Sabé N, Fiol M, Riera L, Etcheverry B, Codina S, Coloma A, Carreras-Salinas A, Ardanuy C, Cruzado JM, Melilli E. Rau M, et al. Among authors: coloma a. Nefrologia (Engl Ed). 2024 May-Jun;44(3):408-416. doi: 10.1016/j.nefroe.2024.02.011. Epub 2024 Apr 17. Nefrologia (Engl Ed). 2024. PMID: 38637262 Free article. Clinical Trial.
High exposure to tacrolimus is associated with spontaneous remission of recurrent membranous nephropathy after kidney transplantation.
Buxeda A, Caravaca-Fontán F, Vigara LA, Pérez-Canga JL, Calatayud E, Coloma A, Mazuecos A, Rodrigo E, Sancho A, Melilli E, Praga M, Pérez-Sáez MJ, Pascual J. Buxeda A, et al. Among authors: coloma a. Clin Kidney J. 2023 Apr 12;16(10):1644-1655. doi: 10.1093/ckj/sfad077. eCollection 2023 Oct. Clin Kidney J. 2023. PMID: 37779857 Free PMC article.
Changing Trends in the Global Consumption of Treatments Used in Hospitalized Patients for COVID-19: A Time Series Multicentre Study.
Aranda J, Loureiro-Amigo J, Murgadella A, Vàzquez N, Feria L, Muñoz M, Padulles A, Abelenda G, Garcia-Vidal C, Tuset M, Albanell M, Boix-Palop L, Sanmartí-Martínez N, Gómez-Zorrilla S, Echeverria-Esnal D, Rodriguez-Alarcón A, Borjabad B, Coloma A, Carratalà J, Oriol I. Aranda J, et al. Among authors: coloma a. Antibiotics (Basel). 2023 Apr 25;12(5):809. doi: 10.3390/antibiotics12050809. Antibiotics (Basel). 2023. PMID: 37237712 Free PMC article.
Nephrology intervention to avoid acute kidney injury in patients awaiting cardiac surgery: randomized clinical trial.
Codina S, Oliveras L, Ferreiro E, Rovira A, Coloma A, Lloberas N, Melilli E, Hueso M, Sbraga F, Boza E, Vazquez JM, Pérez-Fernández JL, Sabater J, Cruzado JM, Montero N. Codina S, et al. Among authors: coloma a. Front Nephrol. 2024 Nov 13;4:1470926. doi: 10.3389/fneph.2024.1470926. eCollection 2024. Front Nephrol. 2024. PMID: 39606581 Free PMC article.
Hybrid immunity protection against SARS-CoV-2 and severe COVID-19 in kidney transplantation: A retrospective, comparative cohort study.
Favà A, Couceiro C, Calatayud L, Hernandez-Hermida Y, Melilli E, Montero N, Manonelles A, Coloma A, Codina S, Lloberas N, Oliveras L, Lino LA, Galofré C, Sabé N, Gomez-Preciado F, Sandoval D, Pizarro D, Domínguez MA, Cruzado JM. Favà A, et al. Among authors: coloma a. Am J Transplant. 2024 Dec;24(12):2282-2291. doi: 10.1016/j.ajt.2024.07.028. Epub 2024 Aug 7. Am J Transplant. 2024. PMID: 39097095
71 results